Advertisement

Inflammation Research

, Volume 54, Issue 3, pp 127–132 | Cite as

Preventive actions of a high dose of glucosamine on adjuvant arthritis in rats

  • J. Hua
  • S. Suguro
  • S. Hirano
  • K. Sakamoto
  • I. NagaokaEmail author
Original Research Paper

Abstract.

Objective: Glucosamine, a naturally occurring amino monosaccharide has been used to treat or prevent osteoarthritis in humans. In this study, we evaluated the effect of glucosamine on rat adjuvant arthritis, a model of rheumatoid arthritis.

Materials and methods: Adjuvant arthritis was induced in male Wistar rats by injection of Freund’s complete adjuvant (FCA) into the right hind paw, and 300 mg/kg of glucosamine, an extra-dose compared with a regular dose for osteoarthritis patients (1.5 g/day, approximately 25 mg/kg), was orally administered once a day to the arthritic rats for 22 days.

Results: Glucosamine significantly suppressed the increase in arthritis score (p < 0.05) after day 10 of adjuvant injection, and inhibited the swelling of FCA-injected right and -uninjected left hind paws (p < 0.01) after day 18. In addition, histopathological examination of the arthritic joints revealed that glucosamine suppressed synovial hyperplasia, cartilage destruction and inflammatory cell infiltration. Furthermore, glucosamine reduced the production of nitric oxide and prostaglandin E2 in plasma (p < 0.05).

Conclusions: These observations suggest that glucosamine is able to suppress the progression of adjuvant arthritis in rats. Glucosamine may be expected as a novel anti-inflammatory agent for treatment of rheumatoid arthritis.

Key words.

Glucosamine Adjuvant arthritis Synovial hyperplasia Nitric oxide Prostaglandin E2 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Birkhäuser Verlag, Basel 2005

Authors and Affiliations

  • J. Hua
    • 1
  • S. Suguro
    • 1
    • 2
  • S. Hirano
    • 3
  • K. Sakamoto
    • 2
  • I. Nagaoka
    • 1
    Email author
  1. 1.Department of Host Defense and Biochemical Research, School of MedicineJuntendo UniversityBunkyo-ku, TokyoJapan
  2. 2.Koyo Chemical Co., Ltd.Chiyoda-ku, TokyoJapan
  3. 3.Mercian Cleantec CorporationFujisawa, KanagawaJapan

Personalised recommendations